BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12632805)

  • 1. For the last time: stock options are an expense.
    Bodie Z; Kaplan RS; Merton RC
    Harv Bus Rev; 2003 Mar; 81(3):62-71, 140. PubMed ID: 12632805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expensing stock options: a fair-value approach.
    Kaplan RS; Palepu KG
    Harv Bus Rev; 2003 Dec; 81(12):105-8, 126. PubMed ID: 14712549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expensing options solves nothing.
    Sahlman WA
    Harv Bus Rev; 2002 Dec; 80(12):90-6, 134. PubMed ID: 12510541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trying to compensate. Latest ranking of CEO compensation finds stock options still key to pay as experts monitor for effects of SEC rule changes.
    Galloro V; Vesely R; Zigmond J
    Mod Healthc; 2007 Jul; 37(30):6, 14, 16 passim. PubMed ID: 17824144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New thinking on how to link executive pay with performance.
    Rappaport A
    Harv Bus Rev; 1999; 77(2):91-101, 186. PubMed ID: 10387774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pension roulette: have you bet too much on equities?
    Stewart GB
    Harv Bus Rev; 2003 Jun; 81(6):104-9, 138. PubMed ID: 12800721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Executive pay trends and golden parachute tax: a collision on the horizon.
    Johnson DG
    Benefits Q; 2004; 20(1):30-6. PubMed ID: 15015423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Every employee an owner. Really.
    Rosen C; Case J; Staubus M
    Harv Bus Rev; 2005 Jun; 83(6):122-30, 150. PubMed ID: 15938443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who should set CEO pay? The press? Congress? Shareholders?
    Brownstein AR; Panner MJ
    Harv Bus Rev; 1992; 70(3):28-32, 34-5, 38. PubMed ID: 10118002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A real-world way to manage real options.
    Copeland T; Tufano P
    Harv Bus Rev; 2004 Mar; 82(3):90-9, 128. PubMed ID: 15029793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Good times. New accounting rules mean fewer stock options for healthcare CEOs, but the highest paid execs are still raking it in.
    Benko LB; Galloro V; Mantone J
    Mod Healthc; 2005 Aug; 35(31):6-7, 16, 1. PubMed ID: 16114827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversy, salaries rise. Ranking of CEO pay at publicly traded companies shows that as pay rises, so does federal interest in compensation policies.
    Benko LB; Galloro V; Zigmond J
    Mod Healthc; 2006 Jul; 36(30):6-7, 14-5, 1. PubMed ID: 16910088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tread lightly through these accounting minefields.
    Sherman HD; Young SD
    Harv Bus Rev; 2001; 79(7):129-35, 146. PubMed ID: 11447613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are they worth it? Executive compensation, company performance don't always relate at top hospital, post-acute and insurance companies.
    Galloro V; Benko LB
    Mod Healthc; 2003 Aug; 33(31):6-7, 14, 1. PubMed ID: 12931471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CEO incentives-its not how much you pay, but how.
    Jensen MC; Murphy KJ
    Harv Bus Rev; 1990; 68(3):138-49. PubMed ID: 10104519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the effect of pharmaceutical firm drug announcements on stock option pricing.
    Younis MM; Younies H; Kisa A; Hartmann M; Hussain AA; Al-Amro A
    J Health Care Finance; 2009; 35(3):35-43. PubMed ID: 19891206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sales compensation governance: the last frontier of corporate reform.
    Gundy PR; Gaeta EC
    Benefits Q; 2004; 20(1):37-43. PubMed ID: 15015424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value rules: senior management incentives in the post-option era.
    Ericson R
    Benefits Q; 2004; 20(1):23-9. PubMed ID: 15015422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's wrong with executive compensation? A roundtable moderated by Charles Elson.
    Roiter E; Clapman P; Heard J; Bachelder J; England J; Lau G; Woolard ES; Meyer P; Hall B; Barnette H; Batts W; Veasey EN
    Harv Bus Rev; 2003 Jan; 81(1):68-77. PubMed ID: 12545924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a share buyback right for your company?
    Pettit J
    Harv Bus Rev; 2001 Apr; 79(4):141-7, 170. PubMed ID: 11299690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.